Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

1. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

   Veronika Blum, Beat Müller, Silvia Höfer +7

   МақолаCancer Immunotherapy and BiomarkersEuropean Journal of Dermatology20180 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000039

2. CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

   Xiao Lyu, Na Zhu, Ruijuan Guo +1

   МақолаCAR-T cell therapy researchCell Biology International20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.012258